News for Hikma Pharmaceuticals PLC (HKMPY)

Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in Canada LONDON and

**media[571897,571898]**

Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in Canada

Fourth Quarter 2024 Total Revenues of $194.7 million; Full Year 2024 Total Revenues of $1.04 billionFourth Quarter 2024 Net Loss of $31.3 million, decrease in N

Release Date: February 26, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Hikma Pharma

Feb 26, 2025 / 09:00AM GMTRiad Mishlawi - Hikma Pharmaceuticals PLC - Chief Executive Officer, Executive Director Thank you for joining our 2024 full-year resul

U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 1.23%

U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 1.38%

The Cancer Cachexia Market Size sector reached a market value of USD 2.02 Billion in 2019. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 5% from 2019 to 2032…

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, Growing at a CAGR of 20.00%...

The need for antiemetic drugs, which help prevent or relieve nausea and vomiting, is growing for several reasons. A key factor is the rising incidence of...

Huntingtons disease treatment industry is projected to witness a CAGR of 20.8% during the period 2024-2032. This growth can be attributed to the limited...

U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 1.05%

U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.37%

Global Mental Health Market size was valued at USD 413.60 billion in 2023 to USD 544.63 billion by 2031, at a CAGR of 3.5% during the forecast period...

Amphastar Pharmaceuticals has seen significant growth since its IPO, with its stock price increasing over 500%. Learn more about AMPH stock here.

Opioid overdose menace causing ill effects on brain functioning and pushing demand for supportive treatment options....

Berenberg upgrades Hikma Pharmaceuticals on renewed growth confidence

The contact-lens induced infections industry is analyzed across different global regions, including Asia Pacific, North America, and Europe. In Asia...